◆ TICKERBASEOpen interactive view →
◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY
Home › All stocks › H › HESTERBIO

Hester Biosciences Limited (HESTERBIO) Financial History

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Drug Manufacturers - Specialty & Generic · DATA UPDATED 2026-09-20

Hester Biosciences Limited (HESTERBIO) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Mehsana, India with about 483 employees. Its market capitalization is roughly ₹19 billion. In the fiscal year ended 2026-03-31, HESTERBIO reported ₹3.3B in revenue and ₹556M in net income.

Hester Biosciences Limited manufactures and trades in veterinary vaccines and health products in India and internationally. It operates through two segments, Poultry Healthcare and Animal Healthcare.

Interactive charts & full statements →

HESTERBIO Revenue & Earnings History — Annual Income Statement

Income statement2026-03-312025-03-312024-03-312023-03-31
Total Revenue₹3.3B₹3.1B₹3.0B₹2.7B
Gross Profit₹2.4B₹2.1B₹1.9B₹1.8B
Operating Income (EBIT)₹771M₹452M₹423M₹416M
Net Income₹556M₹275M₹189M₹266M

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

HESTERBIO Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-31
Total Revenue₹772M₹1.0B₹774M₹710M₹841M——
Gross Profit₹602M₹807M₹567M₹516M₹616M——
Operating Income (EBIT)₹157M₹284M₹134M₹74M₹186M——
Net Income₹970M₹160M₹88M₹144M₹164M——

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

HESTERBIO Free Cash Flow History

Cash flow2026-03-312025-03-312024-03-312023-03-312022-03-31
Dividends Paid(₹60M)(₹52M)(₹68M)(₹85M)—

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

HESTERBIO Balance Sheet History

Balance sheet2026-03-312025-03-312024-03-312023-03-312022-03-31
Total Assets₹6.8B₹6.5B₹6.6B₹6.7B—
Total Liabilities₹3.1B₹3.3B₹3.6B₹3.8B—

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive HESTERBIO viewer.

Other Companies in Drug Manufacturers - Specialty & Generic

← HESSAll “H” companiesHEUR →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.